Series D funding round for Recursion Pharmaceuticals raising $240M in September 2020
Series D funding round for Recursion Pharmaceuticals raising $240M in September 2020
| Investor | Firm Type |
|---|
| Partner |
|---|
Leaps by BayerLEAD | Corporate Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 8 funding rounds. Current round is highlighted.
Total Raised
$509.5M
Top Valuation
-
Recursion Pharmaceuticals raised $240M in a Series D round.
The round was announced on 09/01/20.
The round was led by Juergen Eckhardt.